DYSMORPHISM side effect
What is DYSMORPHISM ?Drugs associated with DYSMORPHISM
ABILIFY ACCUTANE CARBAMAZEPINE COMBIVIR COZAAR EFFEXOR EPILIM EPITOMAX FLUOXETINE LOVAN NOROXIN PAROXETINE RIVOTRIL SEPTRA TEGRETOL VALPROATE WARFARINDYSMORPHISM : Noroxin Side Effects Report #5586105-0
Health Professional from FRANCE reported NOROXIN problem on Apr 28, 2005. Male patient was diagnosed with cystitis and was treated with NOROXIN. After drug was administered, patient experienced the following problems/side effects: dysmorphism, heart disease congenital, limb malformation, . NOROXIN dosage: unknown. During the same period patient was treated with HELICIDINE, MAGNESIUM LACTATE AND PYRIDOXINE HYDROCHLORIDE, FOLIC ACID. Patient recovered.
DYSMORPHISM : Paroxetine Side Effects Report #5518273-0
PAROXETINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 13, 2007. Female patient was diagnosed with depression and was treated with PAROXETINE. After drug was administered, patient experienced the following problems/side effects: dysmorphism, polydactyly, . PAROXETINE dosage: unknown. During the same period patient was treated with AMITRIPTYLINE. Patient recovered.
DYSMORPHISM : Abilify Side Effects Report #5448581-3
Health Professional from GERMANY reported ABILIFY problem on Sept 06, 2007. Female patient was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: dysmorphism, meningomyelocele, premature baby, tethered cord syndrome, vesicoureteric reflux, . ABILIFY dosage: unknown. Patient recovered.
DYSMORPHISM : Epitomax Side Effects Report #5674105-1
EPITOMAX problem was reported by a Health Professional from FRANCE on Mar 14, 2008. Female patient, weighting 5.80 lb, was treated with EPITOMAX. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, dysmorphism, foetal growth retardation, laryngomalacia, pulmonary hypertension, ventricular septal defect, . EPITOMAX dosage: unknown. During the same period patient was treated with DEPAKENE. Patient recovered.
DYSMORPHISM : Effexor Side Effects Report #5627864-8
Physician from IRELAND reported EFFEXOR problem on Feb 06, 2008. Female patient was treated with EFFEXOR. After drug was administered, patient experienced the following problems/side effects: dysmorphism, stillbirth, . EFFEXOR dosage: 225 MG EVERY. During the same period patient was treated with FLUOXETINE. Patient died.
DYSMORPHISM : Cozaar Side Effects Report #5581018-2
COZAAR problem was reported by a Health Professional from CANADA on Dec 21, 2007. Male patient, weighting 4.41 lb, was diagnosed with pregnancy induced hypertension and was treated with COZAAR. After drug was administered, patient experienced the following problems/side effects: congenital musculoskeletal anomaly, dysmorphism, pulmonary malformation, renal failure, skull malformation, stillbirth, . COZAAR dosage: unknown. During the same period patient was treated with ALDOMET. Patient died.
DYSMORPHISM : Cozaar Side Effects Report #5594028-6
Health Professional from CANADA reported COZAAR problem on May 08, 2000. Male patient, weighting 4.41 lb, was diagnosed with pregnancy induced hypertension and was treated with COZAAR. After drug was administered, patient experienced the following problems/side effects: congenital musculoskeletal anomaly, dysmorphism, pulmonary malformation, renal failure, skull malformation, stillbirth, . COZAAR dosage: unknown. During the same period patient was treated with ALDOMET. Patient died.
DYSMORPHISM : Paroxetine Side Effects Report #5537093-4
PAROXETINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 16, 2007. Female patient was diagnosed with depression and was treated with PAROXETINE. After drug was administered, patient experienced the following problems/side effects: dysmorphism, polydactyly, . PAROXETINE dosage: 20 MG; TRPL. During the same period patient was treated with AMITRIPTYLINE. Patient recovered.
DYSMORPHISM : Paroxetine Side Effects Report #5548074-9
Health Professional from UNITED KINGDOM reported PAROXETINE problem on Nov 20, 2007. Female patient was treated with PAROXETINE. After drug was administered, patient experienced the following problems/side effects: dysmorphism, polydactyly, . PAROXETINE dosage: 20 MG, TRANSPLACENTAL. During the same period patient was treated with AMITRIPTYLINE. Patient recovered.
DYSMORPHISM : Accutane Side Effects Report #5565574-6
ACCUTANE problem was reported by a Health Professional from UNITED STATES on Nov 29, 2005. Female patient was diagnosed with acne and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: dysmorphism, heart disease congenital, hydrocephalus, . ACCUTANE dosage: unknown. Patient died.
DYSMORPHISM : Paroxetine Side Effects Report #5578102-6
Health Professional from UNITED KINGDOM reported PAROXETINE problem on Dec 06, 2007. Female patient was treated with PAROXETINE. After drug was administered, patient experienced the following problems/side effects: dysmorphism, polydactyly, . PAROXETINE dosage: 20 MG, TRANSPLACENTAL. During the same period patient was treated with AMITRIPTYLINE. Patient recovered.
DYSMORPHISM : Warfarin Side Effects Report #5511089-0
WARFARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2007. Female patient was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: congenital hydrocephalus, dysmorphism, premature baby, . WARFARIN dosage: unknown. Patient recovered.
DYSMORPHISM : Warfarin Side Effects Report #5529636-1
Consumer or non-health professional from UNITED STATES reported WARFARIN problem on Nov 15, 2007. Male patient, weighting 4.75 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: congenital hydrocephalus, dysmorphism, foetal warfarin syndrome, premature baby, . WARFARIN dosage: unknown. During the same period patient was treated with EPOPROSTENOL. Patient was hospitalized. Patient recovered.
DYSMORPHISM : Paroxetine Side Effects Report #5531251-0
PAROXETINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 13, 2007. Female patient was treated with PAROXETINE. After drug was administered, patient experienced the following problems/side effects: dysmorphism, polydactyly, . PAROXETINE dosage: unknown. During the same period patient was treated with AMITRIPTYLINE. Patient recovered.
DYSMORPHISM : Fluoxetine Side Effects Report #5450074-4
Physician from AUSTRALIA reported FLUOXETINE problem on Sept 04, 2007. Female patient was diagnosed with depression and was treated with FLUOXETINE. After drug was administered, patient experienced the following problems/side effects: dysmorphism, . FLUOXETINE dosage: unknown. Patient recovered.
DYSMORPHISM : Valproate Side Effects Report #5392658-8
VALPROATE problem was reported by a Consumer or non-health professional from FRANCE on July 11, 2007. Female patient was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, dysmorphism, foetal anticonvulsant syndrome, neurodevelopmental disorder, . VALPROATE dosage: unknown. Patient recovered.
DYSMORPHISM : Epilim Side Effects Report #5392674-6
Consumer or non-health professional from FRANCE reported EPILIM problem on July 11, 2007. Male patient was treated with EPILIM. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, dysmorphism, foetal anticonvulsant syndrome, hypospadias, learning disorder, visual disturbance, . EPILIM dosage: unknown. Patient recovered.
DYSMORPHISM : Valproate Side Effects Report #5392658-8
VALPROATE problem was reported by a Consumer or non-health professional from FRANCE on July 11, 2007. Female patient was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, dysmorphism, foetal anticonvulsant syndrome, neurodevelopmental disorder, . VALPROATE dosage: unknown. Patient recovered.
DYSMORPHISM : Epilim Side Effects Report #5392674-6
Consumer or non-health professional from FRANCE reported EPILIM problem on July 11, 2007. Male patient was treated with EPILIM. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, dysmorphism, foetal anticonvulsant syndrome, hypospadias, learning disorder, visual disturbance, . EPILIM dosage: unknown. Patient recovered.
DYSMORPHISM : Rivotril Side Effects Report #5623260-8
RIVOTRIL problem was reported by a Physician from FRANCE on Jan 31, 2008. Male patient, weighting 4.41 lb, was treated with RIVOTRIL. After drug was administered, patient experienced the following problems/side effects: agitation, cleft palate, dysmorphism, foetal growth retardation, hypotonia neonatal, . RIVOTRIL dosage: unknown. During the same period patient was treated with DEPAKOTE, MEPRONIZINE. Patient was hospitalized. Patient recovered.
DYSMORPHISM : Tegretol Side Effects Report #5638993-7
Physician from GERMANY reported TEGRETOL problem on Feb 20, 2008. Female patient, weighting 123.5 lb, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cerebral disorder, dysmorphism, hypermobility syndrome, mental impairment, . TEGRETOL dosage: unknown. Patient recovered.
DYSMORPHISM : Paroxetine Side Effects Report #5532859-9
PAROXETINE problem was reported by a Health Professional from UNITED KINGDOM on Nov 29, 2007. Female patient was diagnosed with depression and was treated with PAROXETINE. After drug was administered, patient experienced the following problems/side effects: congenital anomaly, dysmorphism, polydactyly, . PAROXETINE dosage: 20 MG; TRANSPLACENTAL. During the same period patient was treated with AMITRIPTYLINE. Patient recovered.
DYSMORPHISM : Carbamazepine Side Effects Report #5477663-5
Consumer or non-health professional from ITALY reported CARBAMAZEPINE problem on Sept 17, 2007. Female patient was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: congenital cystic kidney disease, dysmorphism, . CARBAMAZEPINE dosage: 650 MG TRANSPLACENTAL. During the same period patient was treated with PHENOBARBITAL. Patient recovered.
DYSMORPHISM : Effexor Side Effects Report #5450278-0
EFFEXOR problem was reported by a Physician from UNITED KINGDOM on Sept 05, 2007. Female patient was treated with EFFEXOR. After drug was administered, patient experienced the following problems/side effects: congenital anomaly, dysmorphism, feeding disorder, motor dysfunction, . EFFEXOR dosage: unknown. Patient recovered.
DYSMORPHISM : Carbamazepine Side Effects Report #5452006-1
Consumer or non-health professional from ITALY reported CARBAMAZEPINE problem on Sept 03, 2007. Female patient, weighting 0.06 lb, was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: congenital cystic kidney disease, dysmorphism, ectopic kidney, prominent epicanthal folds, . CARBAMAZEPINE dosage: unknown. During the same period patient was treated with PHENOBARBITAL, FOLIC ACID. Patient recovered.
DYSMORPHISM : Lovan Side Effects Report #5455119-3
LOVAN problem was reported by a Consumer or non-health professional from AUSTRALIA on Aug 23, 2007. Female patient was treated with LOVAN. After drug was administered, patient experienced the following problems/side effects: congenital anomaly, dysmorphism, pregnancy, . LOVAN dosage: unknown. Patient recovered.
DYSMORPHISM : Combivir Side Effects Report #5426166-2
Health Professional from UNITED STATES reported COMBIVIR problem on Aug 20, 2007. Male patient, weighting 6.83 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: congenital hand malformation, dysmorphism, jaundice, macrocephaly, patent ductus arteriosus, rash, trisomy 21, ventricular septal defect, . COMBIVIR dosage: unknown. During the same period patient was treated with ZIDOVUDINE, NELFINAVIR. Patient was hospitalized. Patient recovered.
DYSMORPHISM : Septra Side Effects Report #5386298-4
SEPTRA problem was reported by a Consumer or non-health professional from CANADA on July 03, 2007. Female patient was treated with SEPTRA. After drug was administered, patient experienced the following problems/side effects: congenital anomaly, deafness congenital, dysmorphism, ear malformation, grand mal convulsion, limb malformation, multiple congenital abnormalities, spine malformation, urinary tract malformation, . SEPTRA dosage: unknown. During the same period patient was treated with FLUCONAZOLE, METHADONE HYDROCHLORIDE, PENTAMIDINE ISETHIONATE, EFAVIRENZ, NEVIRAPINE. Patient recovered.
DYSMORPHISM : Carbamazepine Side Effects Report #5388660-2
Consumer or non-health professional from ITALY reported CARBAMAZEPINE problem on June 28, 2007. Female patient was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: congenital cystic kidney disease, dysmorphism, ectopic kidney, prominent epicanthal folds, solitary kidney, . CARBAMAZEPINE dosage: unknown. During the same period patient was treated with PHENOBARBITAL, FOLIC ACID. Patient recovered.
DYSMORPHISM : Epilim Side Effects Report #5392573-X
EPILIM problem was reported by a Consumer or non-health professional from FRANCE on July 11, 2007. Male patient was treated with EPILIM. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, attention deficit/hyperactivity disorder, dysmorphism, foetal anticonvulsant syndrome, heart disease congenital, hypokinesia, speech disorder developmental, . EPILIM dosage: unknown. Patient recovered.
DYSMORPHISM : Valproate Side Effects Report #5392582-0
Consumer or non-health professional from FRANCE reported VALPROATE problem on July 11, 2007. Male patient was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, developmental delay, dysmorphism, foetal anticonvulsant syndrome, hypospadias, . VALPROATE dosage: unknown. Patient recovered.
DYSMORPHISM : Epilim Side Effects Report #5392655-2
EPILIM problem was reported by a Consumer or non-health professional from FRANCE on July 11, 2007. Male patient was treated with EPILIM. After drug was administered, patient experienced the following problems/side effects: cataract, congenital jaw malformation, dysmorphism, foetal anticonvulsant syndrome, foot deformity, heart disease congenital, hypertelorism of orbit, hypospadias, neurodevelopmental disorder, . EPILIM dosage: unknown. Patient recovered.
DYSMORPHISM : Valproate Side Effects Report #5392656-4
Consumer or non-health professional from FRANCE reported VALPROATE problem on July 11, 2007. Female patient was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, developmental delay, dysmorphism, epilepsy, foetal anticonvulsant syndrome, foot deformity, ligament laxity, neural tube defect, otitis media, . VALPROATE dosage: unknown. Patient recovered.
DYSMORPHISM : Epilim Side Effects Report #5392692-8
EPILIM problem was reported by a Consumer or non-health professional from FRANCE on July 11, 2007. Female patient was treated with EPILIM. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, deafness, dysmorphism, extremity contracture, foetal anticonvulsant syndrome, kidney malformation, myopia, neurodevelopmental disorder, . EPILIM dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, CLONAZEPAM. Patient recovered.
DYSMORPHISM : Septra Side Effects Report #5386298-4
Consumer or non-health professional from CANADA reported SEPTRA problem on July 03, 2007. Female patient was treated with SEPTRA. After drug was administered, patient experienced the following problems/side effects: congenital anomaly, deafness congenital, dysmorphism, ear malformation, grand mal convulsion, limb malformation, multiple congenital abnormalities, spine malformation, urinary tract malformation, . SEPTRA dosage: unknown. During the same period patient was treated with FLUCONAZOLE, METHADONE HYDROCHLORIDE, PENTAMIDINE ISETHIONATE, EFAVIRENZ, NEVIRAPINE. Patient recovered.
DYSMORPHISM : Carbamazepine Side Effects Report #5388660-2
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from ITALY on June 28, 2007. Female patient was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: congenital cystic kidney disease, dysmorphism, ectopic kidney, prominent epicanthal folds, solitary kidney, . CARBAMAZEPINE dosage: unknown. During the same period patient was treated with PHENOBARBITAL, FOLIC ACID. Patient recovered.
DYSMORPHISM : Epilim Side Effects Report #5392573-X
Consumer or non-health professional from FRANCE reported EPILIM problem on July 11, 2007. Male patient was treated with EPILIM. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, attention deficit/hyperactivity disorder, dysmorphism, foetal anticonvulsant syndrome, heart disease congenital, hypokinesia, speech disorder developmental, . EPILIM dosage: unknown. Patient recovered.
DYSMORPHISM : Valproate Side Effects Report #5392582-0
VALPROATE problem was reported by a Consumer or non-health professional from FRANCE on July 11, 2007. Male patient was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, developmental delay, dysmorphism, foetal anticonvulsant syndrome, hypospadias, . VALPROATE dosage: unknown. Patient recovered.
DYSMORPHISM : Epilim Side Effects Report #5392655-2
Consumer or non-health professional from FRANCE reported EPILIM problem on July 11, 2007. Male patient was treated with EPILIM. After drug was administered, patient experienced the following problems/side effects: cataract, congenital jaw malformation, dysmorphism, foetal anticonvulsant syndrome, foot deformity, heart disease congenital, hypertelorism of orbit, hypospadias, neurodevelopmental disorder, . EPILIM dosage: unknown. Patient recovered.
DYSMORPHISM : Valproate Side Effects Report #5392656-4
VALPROATE problem was reported by a Consumer or non-health professional from FRANCE on July 11, 2007. Female patient was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, developmental delay, dysmorphism, epilepsy, foetal anticonvulsant syndrome, foot deformity, ligament laxity, neural tube defect, otitis media, . VALPROATE dosage: unknown. Patient recovered.
DYSMORPHISM : Epilim Side Effects Report #5392692-8
Consumer or non-health professional from FRANCE reported EPILIM problem on July 11, 2007. Female patient was treated with EPILIM. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, deafness, dysmorphism, extremity contracture, foetal anticonvulsant syndrome, kidney malformation, myopia, neurodevelopmental disorder, . EPILIM dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, CLONAZEPAM. Patient recovered.